CBT Treatment for Internet Gaming Disorder

Launched by SAHLGRENSKA UNIVERSITY HOSPITAL · Apr 6, 2022

Keywords

ClinConnect Summary

This clinical trial is exploring a new treatment for people who struggle with Internet Gaming Disorder (IGD), which is when gaming becomes an addiction and negatively affects a person's life. The study will test a special program based on cognitive behavioral therapy (CBT), which helps people change their thoughts and behaviors related to gaming. Participants will be randomly assigned to either receive 12 weeks of individual CBT treatment or to a wait-list group that will not receive treatment during that time. The goal is to see if the CBT program can help reduce the symptoms of gaming addiction more effectively than doing nothing for those 12 weeks.

To participate in this trial, individuals need to be at least 16 years old, able to read and speak Swedish, and meet certain criteria for IGD. This means they should show signs of gaming addiction as defined by a specific guideline. However, those with serious mental health issues or who are already receiving similar treatment will not be able to join the study. This trial is not yet recruiting participants, but it aims to provide important information about effective ways to help people overcome gaming addiction.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Fulfilling 5 out of 9 criteria for IGD according to DSM V
• • ≥ 16 years of age
• • Can read and speak Swedish fluidly.
• Exclusion Criteria:
• • Somatic or psychiatric disease that is contraindicating or severely complicates the implementation of the intervention (e.g., ongoing psychotic, manic or hypomanic episode or neuropsychiatric condition with severe disability)
• • Ongoing increased suicide risk that is considered to make it inappropriate for the patient to participate in the study (based on evaluation at the structured clinical interview)
• • have another ongoing psychological treatment with a content similar to that in the current study
• • plan to start such treatment during the XX weeks that the study is ongoing or has during the last three weeks started or changed medication for any psychiatric problem.